Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Yves Beguin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Physiology

Erythropoiesis

Chemicals & Drugs

Disorders

Anatomy

Hematopoietic Stem Cells

Concepts & Ideas

Treatment Outcome

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
79
Fillet, Georges
40
Baron, Frédéric
17
Baudoux, Etienne
17
Frère, Pascale
15
Fassotte, Marie-France
15
Gothot, André
12
Sautois, Brieuc
12
Cazzola, Mario
11
Schaaf-Lafontaine, Nicole
10
Jerusalem, Guy
9
Hermanne, Jean-Philippe
8
Loo, M
8
Ponchio, Luisa
7
Hustinx, Roland
6
Herens, Christian

Sign-in to see all Coauthors

Publications

TOP 3
Relic Biserka; Zeddou Mustapha; Desoroux Aline; Beguin Yves; de Seny Dominique; Malaise Michel G
Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts.
Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G
[Monoclonal antibodies in hematology in 2009]
Foguenne Jacques; Di Stefano Ivano; Giet Olivier; Beguin Yves; Gothot André
Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Yves Beguin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Relic Biserka; Zeddou Mustapha; Desoroux Aline; Beguin Yves; de Seny Dominique; Malaise Michel G
Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts.
Laboratory investigation; a journal of technical methods and pathology 2009;89(7):811-22.
2009: Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G
[Monoclonal antibodies in hematology in 2009]
Revue médicale de Liège 2009;64(5-6):268-73.
2009: Foguenne Jacques; Di Stefano Ivano; Giet Olivier; Beguin Yves; Gothot André
Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.
Haematologica 2009;94(2):185-94.
2009: Willems E; Canivet J-L; Ghaye B; de Leval L; Radermecker M; Preiser J-C; Beguin Y
Pulmonary veno-occlusive disease in myeloproliferative disorder.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2009;33(1):213-6.
2009: Morrhaye Gabriel; Kermani Hamid; Legros Jean-Jacques; Baron Frederic; Beguin Yves; Moutschen Michel; Cheynier Remi; Martens Henri J; Geenen Vincent
Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.
PloS one 2009;4(5):e5668.
2008: Hoyoux Claire; Dresse Marie Françoise; Robinet Sébastien; Forget Patricia; Pieltain Catherine; Ketelslegers Olivier; Beguin Yves
Cord blood transplantation in a child with Pearson's disease.
Pediatric blood & cancer 2008;51(4):566.
2008: Lejeune M; Beguin Y; De Prijck B; Fassotte M F; Fillet G; Baron F
[How I treat... Acute myeloid leukemia in older patients with good performance status]
Revue médicale de Liège 2008;63(2):59-63.
2008: Castermans Emilie; Baron Frédéric; Willems Evelyne; Schaaf-Lafontaine Nicole; Meuris Nathalie; Gothot André; Vanbellighen Jean-François; Herens Christian; Seidel Laurence; Geenen Vincent; Cheynier Remi; Beguin Yves
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Haematologica 2008;93(2):240-7.
2007: Castermans E; Morrhaye G; Marchand S; Martens H; Moutschen M; Geenen V; Beguin Y; Baron F
[Evaluation of thymopoiesis: clinical applications]
Revue médicale de Liège 2007;62(12):725-9.
2007: Castermans E; Morrhaye G; Marchand S; Martens H; Moutschen M; Baron F; Beguin Y; Geenen V
[Clinical evaluation of thymic function]
Revue médicale de Liège 2007;62(11):675-8.
2007: Bonnet Christophe; Beguin Yves; Fassotte Marie-France; Seidel Laurence; Luyckx Françoise; Fillet Georges
Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
European journal of haematology 2007;78(5):399-404.
2007: Bovy Christophe; Gothot André; Delanaye Pierre; Warling Xavier; Krzesinski Jean-Marie; Beguin Yves
Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(4):1156-62.
2006: Baron F; Vanstraelen G; Beguin Y
Transfusions after nonmyeloablative or reduced-intensity conditioning regimens.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(12):2081-6.
2006: Bovy Christophe; Baudoux Etienne; Salmon Jean Pol; Beguin Yves
Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
Transfusion 2006;46(9):1616-23.
2006: Van Overstraeten-Schlögel Nancy; Delgaudine Marie; Beguin Yves; Gothot André
Limitations of the use of GFP transgenic mice in bone marrow transplantation studies.
Leukemia & lymphoma 2006;47(7):1392-3.
2006: Vanstraelen Gaëtan; Baron Frédéric; Willems Evelyne; Bonnet Christophe; Hafraoui Kaoutar; Frère Pascale; Fillet Georges; Beguin Yves
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Experimental hematology 2006;34(7):841-50.
2006: Pirson Laurence; Baron Frédéric; Meuris Nathalie; Giet Olivier; Castermans Emilie; Greimers Roland; Di Stefano Ivano; Gothot André; Beguin Yves
Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
Stem cells (Dayton, Ohio) 2006;24(7):1814-21.
2006: Van Overstraeten-Schlögel Nancy; Beguin Yves; Gothot André
Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
European journal of haematology 2006;76(6):488-93.
2006: Vanstraelen Gaëtan; Frère Pascale; Ngirabacu Marie-Christine; Willems Evelyne; Fillet Georges; Beguin Yves
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.
Experimental hematology 2006;34(3):382-8.
2006: Frère P; Baron F; Bonnet C; Hafraoui K; Pereira M; Willems E; Fillet G; Beguin Y
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen.
Bone marrow transplantation 2006;37(4):411-8.
2006: Frère Pascale; Pereira Maguy; Fillet Georges; Beguin Yves
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
European journal of haematology 2006;76(2):102-8.
2005: Vanstraelen Gaëtan; Baron Frédéric; Frère Pascale; Hafraoui Kaoutar; Fillet Georges; Beguin Yves
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.
Haematologica 2005;90(9):1269-70.
2005: Jerusalem Guy; Hustinx Roland; Beguin Yves; Fillet Georges
Positron emission tomography imaging for lymphoma.
Current opinion in oncology 2005;17(5):441-5.
2005: Willems E; Baron F; Vanstraelen G; Frère P; Fillet G; Beguin Y
[Nonmyeloablative stem cell transplantation as cancer immunotherapy]
Revue médicale suisse 2005;1(30):1973-7.
2005: Jerusalem Guy; Hustinx Roland; Beguin Yves; Fillet Georges
Evaluation of therapy for lymphoma.
Seminars in nuclear medicine 2005;35(3):186-96.
2005: Bovy Christophe; Gothot André; Krzesinski Jean-Marie; Beguin Yves
Mature erythrocyte indices: new markers of iron availability.
Haematologica 2005;90(4):549-51.
2005: Foguenne Jacques; Huygen Sandra; Greimers Roland; Beguin Yves; Gothot André
Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion.
Haematologica 2005;90(4):445-51.
2005: Bataille Y; Bovy C; Lancellotti P; Melchior V; Delbecque K; Beguin Y; Krzesinski J M
Primary amyloidosis (AL) as a cause of nephrotic syndrome.
Acta clinica Belgica 2005;60(2):94-7.
2005: Piette C; Dresse M F; Forget P; Schmitz V; Demarche M; Erpicum P; Closon M T; Rutten I; Paulus P; Vivegnis D; Beguin Y; Jamblin P; Hoyoux Cl
[Clinical evaluation of 23 children with neuroblastoma. The experience of a single institution]
Revue médicale de Liège 2005;60(3):173-80.
2004: Baron Frédéric; Copizza Sandra; Baudoux Etienne; Jerusalem Guy; Fillet Georges; Beguin Yves
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer.
Haematologica 2004;89(9):1146-8.
2004: Bovy Christophe; Krzesinski Jean-Marie; Gothot André; Beguin Yves
Impact of erythropoietic activity on red cell parameters in chronic renal failure patients.
Haematologica 2004;89(6):748-9.
2004: Frère P; Hermanne J-P; Debouge M-H; de Mol P; Fillet G; Beguin Y
Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures.
Bone marrow transplantation 2004;33(7):745-9.
2003: Baron Frédéric; Schaaf-Lafontaine Nicole; Humblet-Baron Stéphanie; Meuris Nathalie; Castermans Emilie; Baudoux Etienne; Frère Pascale; Bours Vincent; Fillet Georges; Beguin Yves
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Transplantation 2003;76(12):1705-13.
2003: Humblet-Baron Stéphanie; Baron Frédéric; Beguin Yves; Chachati Alfred; Bury Jean; Morelon Emmanuel; Kreis Henri
Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Transplantation 2003;76(10):1531-2.
2003: Baron Frédéric; Frère Pascale; Fillet Georges; Beguin Yves
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5566-72.
2003: Baron F; Baudoux E; Frère P; Tourqui S; Schaaf-Lafontaine N; Herens C; DePrijck B; Fillet G; Beguin Y
Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC.
Bone marrow transplantation 2003;32(8):829-34.
2003: Baron Frédéric; Frère Pascale; Fillet Georges; Beguin Yves
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.
British journal of haematology 2003;123(1):103-5.
2003: Gothot André; Giet Olivier; Huygen Sandra; Beguin Yves
Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells.
Leukemia & lymphoma 2003;44(8):1379-83.
2003: Baron Frederic; Dresse Marie-Françoise; Beguin Yves
Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation.
The New England journal of medicine 2003;349(9):913-4.
2003: Cazzola Mario; Beguin Yves; Kloczko Janusz; Spicka Ivan; Coiffier Bertrand
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
British journal of haematology 2003;122(3):386-93.
2003: Baron Frédéric; Frère Pascale; Baudoux Etienne; Schaaf-Lafontaine Nicole; Fillet Georges; Beguin Yves
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.
Haematologica 2003;88(7):835-7.
2003: Baron Frédéric; Frère Pascale; Beguin Yves
Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment.
Haematologica 2003;88(6):718-20.
2003: Baron Frédéric; Frère Pascale; Baudoux Etienne; Sautois Brieuc; Fillet Georges; Beguin Yves
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Haematologica 2003;88(4):478-80.
2003: Beguin Yves
Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.
Clinica chimica acta; international journal of clinical chemistry 2003;329(1-2):9-22.
2003: Beguin Y; Baron F
Minitransplants: allogeneic stem cell transplantation with reduced toxicity.
Acta clinica Belgica 2003;58(1):37-45.
2003: Hafraoui K; Humblet-Baron S; Baron F; Beguin Y; Fillet G
[How I treat...chronic myeloid leukemia]
Revue médicale de Liège 2003;58(1):7-12.
2003: André Marc; Baudoux Etienne; Bron Dominique; Canon Jean-Luc; D'Hondt Véronique; Fassotte Marie-France; D'Hondt Lionel; Fillet Georges; Humblet Yves; Jerusalem Guy; Vermeulen Philippe; Symann Michel; Beguin Yves
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.
Transfusion 2003;43(1):50-7.
2003: Jerusalem G; Beguin Y; Fassotte M F; Belhocine T; Hustinx R; Rigo P; Fillet G
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):123-30.
2002: Warland V; Jérusalem G; Hustinx R; Beguin Y; Silvestre R M; Fassotte M F; Foidart-Willems J; Fillet G
[End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma]
Revue médicale de Liège 2002;57(12):779-84.
2002: Baron Frédéric; Frère Pascale; Herens Christian; Fillet Georges; Beguin Yves
Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
Haematologica 2002;87(12):ECR43.
2002: Baron F; Fillet G; Beguin Y
Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.
Transplantation 2002;74(12):1692-6.
2002: Beguin Y; Benoit Y; Crokaert F; Selleslag D; Vandercam B;
Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.
Acta clinica Belgica 2002;57(6):309-16.
2002: Huygen Sandra; Giet Olivier; Artisien Vincent; Di Stefano Ivano; Beguin Yves; Gothot André
Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture.
Blood 2002;100(8):2744-52.
2002: Baron Frédéric; Baudoux Etienne; Fillet Georges; Beguin Yves
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
Hematology (Amsterdam, Netherlands) 2002;7(3):137-43.
2002: Baron Frédéric; Sautois Brieuc; Baudoux Etienne; Matus Geoffrey; Fillet Georges; Beguin Yves
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2002;30(6):546-54.
2002: Baron Frédéric; Baudoux Etienne; Frère Pascale; Tourqui Soraya; Schaaf-Lafontaine Nicole; Greimers Roland; Herens Christian; Fillet Georges; Beguin Yves
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells.
Journal of hematotherapy & stem cell research 2002;11(2):301-14.
2002: Baron F; Beguin Y
Nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):243-63.
2002: Frère P; Hermanne J-P; Debouge M-H; Fillet G; Beguin Y
Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients.
Bone marrow transplantation 2002;29(7):589-94.
2002: Giet Olivier; Van Bockstaele Dirk R; Di Stefano Ivano; Huygen Sandra; Greimers Roland; Beguin Yves; Gothot André
Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells.
Blood 2002;99(6):2023-31.
2002: Baron Frédéric; Siquet Jean; Schaaf-Lafontaine Nicole; Baudoux Etienne; Hermanne Jean-Philippe; Fillet Georges; Beguin Yves
Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
Haematologica 2002;87(1):78-88.
2002: Jerusalem G; Hustinx R; Beguin Y; Fillet G
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():227-34.
2002: Baron F; Beguin Y
Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):351-9.
2001: Sautois B; Baudoux E; Salmon J P; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus J M; Fillet G; Beguin Y
Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
Haematologica 2001;86(11):1209-18.
2001: Jerusalem G; Beguin Y; Najjar F; Hustinx R; Fassotte M F; Rigo P; Fillet G
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):825-30.
2001: R'zik S; Beguin Y
Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors.
Experimental hematology 2001;29(6):677-85.
2001: Giet O; Huygen S; Beguin Y; Gothot A
Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin.
Experimental hematology 2001;29(4):515-24.
2001: Jerusalem G; Beguin Y; Fassotte M F; Najjar F; Paulus P; Rigo P; Fillet G
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Haematologica 2001;86(3):266-73.
2001: R'zik S; Loo M; Beguin Y
Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels.
Haematologica 2001;86(3):244-51.
2001: Piron M; Loo M; Gothot A; Tassin F; Fillet G; Beguin Y
Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
Blood 2001;97(2):442-8.
2000: Baron F; Gothot A; Salmon J P; Hermanne J P; Pierard G E; Fillet G; Beguin Y
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
British journal of haematology 2000;111(3):745-53.
2000: Baron F; Dresse M F; Beguin Y
Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease.
Transfusion 2000;40(9):1071-3.
2000: Baron F; Ribbens C; Kaye O; Fillet G; Malaise M; Beguin Y
Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation.
British journal of haematology 2000;110(2):339-42.
2000: Frere P; Canivet J L; Gennigens C; Rebeix J P; Fillet G; Beguin Y
Hyperammonemia after high-dose chemotherapy and stem cell transplantation.
Bone marrow transplantation 2000;26(3):343-5.
2000: Herens C; Tassin F; Lemaire V; Beguin Y; Collard E; Lampertz S; Croisiau C; Lecomte M; De Prijk B; Longrée L; Koulischer L
Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients.
British journal of haematology 2000;110(1):214-6.
2000: Jerusalem G; Beguin Y; Fassotte M F; Najjar F; Paulus P; Rigo P; Fillet G
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
Haematologica 2000;85(6):613-8.
2000: Baron F; Beguin Y
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation.
Transfusion 2000;40(4):468-76.
2000: Ribbens C; Bonnet V; Kaiser M J; Andre B; Kaye O; Franchimont N; de Groote D; Beguin Y; Malaise M G
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA).
Clinical and experimental immunology 2000;120(1):194-9.
2000: Fraipont V; Sautois B; Baudoux E; Pereira M; Fassotte M F; Hermanne J P; Jérusalem G; Longrée L; Schaaf-Lafontaine N; Fillet G; Beguin Y
Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF.
Transfusion 2000;40(3):339-47.
2000: Tassin F; Dewé W; Schaaf N; Herens C; Ravoet C; Albert A; Beguin Y; Paulus J M
A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes.
Leukemia & lymphoma 2000;36(5-6):485-96.
1999: Cazzola M; Beguin Y; Bergamaschi G; Guarnone R; Cerani P; Barella S; Cao A; Galanello R
Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis.
British journal of haematology 1999;106(3):752-5.
1999: Salmon J P; Michaux S; Hermanne J P; Baudoux E; Gérard C; Sontag-Thull D; Fillet G; Beguin Y
Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation.
Transfusion 1999;39(8):824-7.
1999: Dresse M F; Boogaerts M; Vermylen C; Noens L; Ferrant A; Schots R; Doyen C; Bron D; Berneman Z; Ferster A; Benoit Y; Demuynck H; Beguin Y
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.
Haematologica 1999;84(7):637-42.
1999: Jerusalem G; Beguin Y; Fassotte M F; Najjar F; Paulus P; Rigo P; Fillet G
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
Blood 1999;94(2):429-33.
1999: Beguin Y
Erythropoietin and platelet production.
Haematologica 1999;84(6):541-7.
1999: Loo M; Beguin Y
The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.
Blood 1999;93(10):3286-93.
1999: Sautois B; Fraipont V; Baudoux E; Fassotte M F; Hermanne J P; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus J M; Sondag D; Fillet G; Beguin Y
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Haematologica 1999;84(4):342-9.
1999: Cornu G; Vermylen C; Ferster A; Brichard B; Ninane J; Ferrant A; Zenebergh A; Maes P; Dhooge C; Benoit Y; Beguin Y; Dresse M F; Sariban E
[Hematopoietic stem cell transplantation in sickle cell anemia]
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 1999;6 Suppl 2():345s-347s.
1998: Beguin Y; Baron F; Fillet G
Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation.
Haematologica 1998;83(12):1076-81.
1998: Baron F; Hermanne J P; Fassotte M F; Beguin Y; Fillet G
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]
Revue médicale de Liège 1998;53(11):651-3.
1998: Beguin Y
A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.
Drug safety : an international journal of medical toxicology and drug experience 1998;19(4):269-82.
1998: Beguin Y
Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
Medical oncology (Northwood, London, England) 1998;15 Suppl 1():S38-46.
1998: Baudoux E; Beguin Y; Cornu G; Brichard B; Debruyn C; De Bruyère M; De Hemptinne D; Delforge A; Deneys V; Fillet G; Germeau N; Joris I; Lefèvre P; Massy M; Paulus J M; Raymakers N; Schaaps J P; Sondag D; Van Cauwenberge J R; Vermylen C; Strijckmans P
Circadian and seasonal variations of hematopoiesis in cord blood.
Bone marrow transplantation 1998;22 Suppl 1():S12.
1998: Baron F; Sadzot B; Wang F; Beguin Y
Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(2):197-200.
1998: Vermylen C; Cornu G; Ferster A; Brichard B; Ninane J; Ferrant A; Zenebergh A; Maes P; Dhooge C; Benoit Y; Beguin Y; Dresse M F; Sariban E
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.
Bone marrow transplantation 1998;22(1):1-6.
1998: Baron F A; Hermanne J P; Dowlati A; Weber T; Thiry A; Fassotte M F; Fillet G; Beguin Y
Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;21(9):951-4.
1998: Cazzola M; Guarnone R; Cerani P; Centenara E; Rovati A; Beguin Y
Red blood cell precursor mass as an independent determinant of serum erythropoietin level.
Blood 1998;91(6):2139-45.
1998: Beguin Y; Baudoux E; Sautois B; Fraipont V; Schaaf-Lafontaine N; Pereira M; Paulus J M; Sondag D; Fillet G
Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells.
Transfusion 1998;38(2):199-208.
1997: Baron F; Deprez M; Beguin Y
The veno-occlusive disease of the liver.
Haematologica 1997;82(6):718-25.
1997: Beguin Y; Grek V; Weber G; Sautois B; Paquot N; Pereira M; Scheen A; Lefèbvre P; Fillet G
Acute functional iron deficiency in obese subjects during a very-low-energy all-protein diet.
The American journal of clinical nutrition 1997;66(1):75-9.
1997: Dowlati A; R'Zik S; Fillet G; Beguin Y
Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production.
British journal of haematology 1997;97(2):297-9.
1997: Beguin Y; Sautois B; Forget P; Bury J; Fillet G
Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen.
Cancer 1997;79(7):1351-4.
1997: Baron F; Beguin Y
[Hepatic complications of chemotherapy. From trivial cytolysis to hepatic veno-occlusive disease]
Revue médicale de Liège 1997;52(2):93-7.
1997: Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Transfusion 1997;37(2):135-40.
1997: Sautois B; Fillet G; Beguin Y
Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood.
Experimental hematology 1997;25(2):103-8.
1997: Dowlati A; Loo M; Bury T; Fillet G; Beguin Y
Soluble and cell-associated transferrin receptor in lung cancer.
British journal of cancer 1997;75(12):1802-6.
1996: Pasquasy V; Delvenne P; Thiry A; Beguin Y; Boniver J
[Thrombotic thrombocytopenic purpura in bone marrow graft rejection (clin conference)]
Revue médicale de Liège 1996;51(11):714-7.
1996: Cazzola M; Ponchio L; Pedrotti C; Farina G; Cerani P; Lucotti C; Novella A; Rovati A; Bergamaschi G; Beguin Y
Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.
Haematologica 1996;81(5):434-41.
1996: Beguin Y; Collignon J; Laurent C; Fillet G
Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome.
British journal of haematology 1996;94(3):507-9.
1996: Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Blood 1996;87(11):4824-30.
1996: Beguin Y
[Hematopoietic stem cell transplantation ("Bone marrow graft"): indications, methods and risks]
Revue médicale de Liège 1996;51(4):270-5.
1996: Beguin Y; Lampertz S; Bron D; Fillet G
Serum erythropoietin in chronic lymphocytic leukaemia.
British journal of haematology 1996;93(1):154-6.
1995: Beguin Y
[Pharma-clinics. How I treat... anemia (3)]
Revue médicale de Liège 1995;50(12):497-8.
1995: Beguin Y
[How I examine... anemia (2)]
Revue médicale de Liège 1995;50(11):487-8.
1995: Beguin Y
[How I examine... Anemia (1)]
Revue médicale de Liège 1995;50(10):443-4.
1995: Beguin Y
Erythropoiesis and erythropoietin in multiple myeloma.
Leukemia & lymphoma 1995;18(5-6):413-21.
1995: Dowlati A; Honore P; Damas P; Deprez M; Delwaide J; Fillet G; Beguin Y
Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
Transplantation 1995;60(1):106-9.
1995: Cazzola M; De Stefano P; Ponchio L; Locatelli F; Beguin Y; Dessi C; Barella S; Cao A; Galanello R
Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.
British journal of haematology 1995;89(3):473-8.
1995: Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.
British journal of haematology 1995;89(1):17-23.
1994: Locatelli F; Zecca M; Ponchio L; Beguin Y; Giorgiani G; Maccario R; Bonetti F; De Stefano P; Cazzola M
Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14(6):929-35.
1994: Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters.
European journal of haematology 1994;53(5):265-70.
1994: Fraipont V; Beguin Y; Fillet G
[Iron-deficiency anemia in pregnancy]
Revue médicale de Liège 1994;49(8):436-45.
1994: Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
Bone marrow transplantation 1994;13(4):403-10.
1993: Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(12):2019-25.
1993: Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.
Blood 1993;82(7):2010-6.
1993: Locatelli F; Zecca M; Beguin Y; Giorgiani G; Ponchio L; De Stefano P; Cazzola M
Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
British journal of haematology 1993;84(4):752-4.
1993: Beguin Y; Oris R; Fillet G
Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
Bone marrow transplantation 1993;11(4):285-92.
1993: Beguin Y; Clemons G K; Pootrakul P; Fillet G
Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
Blood 1993;81(4):1067-76.
1993: Beguin Y
[Quantitative measures of erythropoiesis. Soluble transferrin receptor]
Bulletin et mémoires de l'Académie royale de médecine de Belgique 1993;148(1-2):100-4; discussion 105-7.
1993: Feron C; Gothot A; Grosdent J C; van Cauwenberge J R; Schaaps J P; Beguin Y; Paulus J M
Purification, expansion, and multiple fluorochrome labeling of cord blood hemopoietic precursors: preliminary results.
Journal of hematotherapy 1993;2(2):259-61.
1992: Beguin Y; Yerna M; Loo M; Weber M; Fillet G
Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production.
British journal of haematology 1992;82(4):648-53.
1992: Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Haematologica 1992;77(6):494-501.
1992: De Groote D; Zangerle P F; Gevaert Y; Fassotte M F; Beguin Y; Noizat-Pirenne F; Pirenne J; Gathy R; Lopez M; Dehart I
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation.
Cytokine 1992;4(3):239-48.
1992: Cazzola M; Beguin Y
New tools for clinical evaluation of erythron function in man.
British journal of haematology 1992;80(3):278-84.
1992: Antoine N; Beckers C; Marcoty C; Bosseloir A; Beguin Y; Schaaf-Lafontaine N; Simar L J
[Expression of DRC1 antigen by leukemic cells]
Revue médicale de Liège 1992;47(2):95-9.
1992: Cazzola M; Ponchio L; Beguin Y; Rosti V; Bergamaschi G; Liberato N L; Fregoni V; Nalli G; Barosi G; Ascari E
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.
Blood 1992;79(1):29-37.
1992: Elira-Dokekias A; R'Zik S; Beguin Y; Fillet G
Monitoring of erythropoiesis by serum transferrin receptor levels in a case of chronic lymphocytic leukaemia and pure red cell aplasia treated with ciclosporin.
Nouvelle revue française d'hématologie 1992;34(3):257-8.
1991: Beguin Y; Lipscei G; Thoumsin H; Fillet G
Blunted erythropoietin production and decreased erythropoiesis in early pregnancy.
Blood 1991;78(1):89-93.
1991: Beguin Y; Clemons G K; Oris R; Fillet G
Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.
Blood 1991;77(4):868-73.
1990: Beguin Y; Lipscei G; Oris R; Thoumsin H; Fillet G
Serum immunoreactive erythropoietin during pregnancy and in the early postpartum.
British journal of haematology 1990;76(4):545-9.
1990: Beguin Y; Fassotte M F; Hay F; Dokekias A; Andrien F; Bours V; Moutschen M; Runde V; Bury J; Fillet G
[Bone marrow grafts: current status at the University Hospital Center in Liège]
Revue médicale de Liège 1990;45(6):268-79.
1990: Beguin Y; Fillet G
[Erythropoietin: diagnostic and therapeutic use]
Revue médicale de Liège 1990;45(6):261-7.
1989: Beguin Y; Bours V; Delbrouck J M; Robaye G; Roelandts I; Bury J; Fillet G; Weber G
Relationship of serum selenium levels to tumor activity in acute non-lymphocytic leukemia.
Carcinogenesis 1989;10(11):2089-91.
1989: Beguin Y; Fillet G; Bury J; Fairon Y
Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis.
American journal of hematology 1989;32(2):123-8.
1989: Fillet G; Beguin Y; Baldelli L
Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation.
Blood 1989;74(2):844-51.
1989: Grek V; Hay F; Beguin Y; Andrien F; Dokekias A; Fillet G
[Hairy cell leukemia: 30 years later]
Revue médicale de Liège 1989;44(10):358-64.
1989: Defraigne J O; Closon M T; Bruyninx L; Dewandre J M; Hourlay P; Meurisse M; Honore P; Bury J; Beguin Y
Experience with a totally implantable catheter in adult patients: a single institution retrospective study of 114 cases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1989;15(1):61-4.
1987: Beguin Y; Brasseur F; Weber G; Bury J; Delbrouck J M; Roelandts I; Robaye G; Fillet G
Observations of serum trace elements in chronic lymphocytic leukemia.
Cancer 1987;60(8):1842-6.
1987: Bury J; Andrien F; Baudrihaye M; Beguin Y; Duvivier A; Hoyoux C; Runde V; Fillet G
[Marrow transplantation: preliminary results at the University Hospital Center]
Revue médicale de Liège 1987;42(10):510-5.
1987: Fillet G; Bury J; Beguin Y; Duvivier A; Hoyoux C; Bours V
[Hematologic cancers in 1987. Chemotherapy and immunotherapy]
Revue médicale de Liège 1987;42(10):496-502.
1987: Beguin Y; Bury J; Delbrouck J M; Fillet G; Robaye G; Roelandts I; Weber G
Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia.
Haematology and blood transfusion 1987;30():380-4.
1986: Beguin Y; Weber G; Delbrouck J M; Roelandts I; Robaye G; Bury J; Fillet G
Serum trace elements during chemotherapy for acute myelogenous leukemia.
Acta pharmacologica et toxicologica 1986;59 Suppl 7():270-3.

Sign-in to see more